Day: September 24, 2024

Continued Investment in Technology & Flexible Capacity, Including New Fill/Finish Capabilities, Fortify the Global Gene Therapy Support Offer at Ascend

LONDON, Sept. 24, 2024 /PRNewswire/ -- Ascend Advanced Therapies (Ascend), a gene to GMP development partner, has confirmed multi-million-dollar investments supporting...

error: Content is protected !!